Zimmer Biomet forecasts 2026 adjusted EPS of $8.47-$8.59 as it raises organic revenue growth to 2.25%-3.25% (NYSE:ZBH)
· seekingalpha.com
Zimmer Biomet (ZBH) Q2 2026 earnings call recap: sales and tech strength, raised revenue/EPS guidance, pricing and China risks.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...